C. Arnaud (Grenoble, France), M. Sanchez De La Torre (Lleida, Spain)
Introduction
C. Arnaud (Grenoble, France), M. Sanchez De La Torre (Lleida, Spain)
|  |
Sleep apnea syndrome and atherosclerosis: VE-Cadherin as a new antiatherogenic target?
O. Harki (Grenoble, France), S. Bouyon (Grenoble, France), E. Lemarié (Grenoble, France), A. Demory (Grenoble, France), C. Chirica (Grenoble, France), I. Vilgrain (Grenoble, France), J. Pépin (Grenoble, France), G. Faury (Grenoble, France), A. Briançon-Marjollet (Grenoble, France)
|    |
Proteomic profiling in patients with acute coronary syndrome and obstructive sleep apnea: A post-hoc analysis from the ISAACC study.
A. Zapater Matute (Madrid, Spain), E. Gracia-Lavedan (Lleida, Spain), G. Torres (Lleida, Spain), A. Sánchez-De-La-Torre (Lleida, Spain), A. Aldoma (Lleida, Spain), O. Mínguez (Lleida, Spain), L. Pascual (Lleida, Spain), A. Cortijo (Lleida, Spain), D. Martínez (Lleida, Spain), I. Benitez (Lleida, Spain), F. Barbé (Lleida, Spain), M. Sánchez-De-La-Torre (Madrid, Spain)
| |
The effect of the GLP-1 analogue Liraglutide on intermittent hypoxia-induced systemic insulin resistance in vivo
A. King (Dublin 4, Ireland), C. Arnaud (Grenoble, France), G. Vial (Grenoble, France), E. Billoir (Grenoble, France), B. Ozcan (Grenoble, France), E. Belaidi (Grenoble, France), C. O'Donnell (Dublin , Ireland), S. Ryan (Dublin , Ireland)
| |
Short-term continuous positive air pressure (CPAP) treatment: effects on cardiac structural changes and function in patients with obstructive sleep apnea (OSA)
L. Kondrataviciene (Kaunas, Lithuania), E. Tamulenaite (Kaunas, Lithuania), E. Ereminiene (Kaunas, Lithuania), S. Miliauskas (Kaunas, Lithuania)
| |
Long non-coding RNA FKSG29 over-expression in patients with obstructive sleep apnea modulates intermittent hypoxia-induced oxidative stress and cell apoptosis via sponging miR-23a-3p-IL6R signaling
Y. Chen (Kaohsiung, Taiwan), M. Lin (Kaohsiung, Taiwan), P. Hsu (Kaohsiung, Taiwan), C. Hsiao (Taoyuan, Taiwan), T. Wang (Kaohsiung, Taiwan)
| |
Polysomnographic characterization of the circadian blood pressure patterns in patients with obstructive sleep apnea
L. Pinilla (Madrid, Spain), O. Mínguez (Lleida, Spain), M. Aguilà (Lleida, Spain), R. Vaca (Lleida, Spain), I. Benítez (Madrid, Spain), G. Torres (Madrid, Spain), O. Mediano (Madrid, Spain), J. Masa (Madrid, Spain), M. Masdeu (Sabadell, Spain), F. Barbé (Madrid, Spain), M. Sánchez-De-La-Torre (Madrid, Spain)
| |
Autophagy impairment in patients with obstructive sleep apnea mediates intermittent hypoxia-induced apoptosis and cytotoxicity via hypermethylation of the MAP1LC3B and ATG5 promoter regions
Y. Chen (Kaohsiung, Taiwan), M. Lin (Kaohsiung, Taiwan), P. Hsu (Kaohsiung, Taiwan), C. Hsiao (Taoyuan, Taiwan), T. Wang (Kaohsiung, Taiwan)
| |
Intermittent hypoxia and pregnancy in a rat model: respiratory and metabolic effectson mothers and offspring
E. Valverde Pérez (Valladolid, Spain), J. Prieto-Lloret (Valladolid, Spain), O. Ríos-Rodríguez (Valladolid, Spain), M. De Pablos (Valladolid, Spain), Á. Gómez-Niño (Valladolid, Spain), R. Rigual (Valladolid, Spain), A. Obeso (Valladolid, Spain), I. Almendros (Barcelona, Spain), R. Farré (Barcelona, Spain), A. Rocher (Valladolid, Spain), E. Olea (Valladolid, Spain)
| |
DYSLIPIDEMIA PREVALENCE IN NON-OBESE NON-DIABETIC PATIENTS WITH OBSTRUCTIVE SLEEP APNEA: DOES SEX MATTER?
O. K. Basoglu (Izmir, Turkey), M. Tasbakan (Izmir, Turkey), M. Kayikcioglu (Izmir, Turkey)
| |
Late Breaking Abstract - Inflammasome activation: A keystone of proinflammatory response in obstructive sleep apnea
E. Díaz (Madrid, Spain), S. García (Madrid, Spain), E. Alfaro (Madrid, Spain), A. Jaureguizar (Madrid, Spain), R. Casitas (Madrid, Spain), B. Sanchez (Madrid, Spain), E. Zamarrón (Madrid, Spain), J. Fernández (Madrid, Spain), F. García (Madrid, Spain), c. cubillos (Madrid, Spain)
| |